세계의 치료 기기 수탁제조 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 서비스별, 치료 영역별, 최종 용도별, 지역별 부문 예측(2025-2033년)
Therapeutic Device Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Services, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2025 - 2033
상품코드
:
1869643
리서치사
:
Grand View Research
발행일
:
2025년 10월
페이지 정보
:
영문 150 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
치료 기기 수탁제조 시장 요약
세계의 치료 기기 수탁제조 시장 규모는 2024년 536억 6,000만 달러로 평가되었으며, 2033년까지 1,597억 6,000만 달러에 이를 것으로 예측됩니다.
2025-2033년까지 CAGR 13.15%로 성장할 전망입니다. 이 시장은 진보된 치료 장치 수요 증가, 의료기기 제조업체의 비용 절감 및 시장 투입 기간 단축을 목적으로 하는 제조 아웃소싱 증가 동향, 혁신적인 치료 솔루션을 필요로 하는 만성 질환의 유병률 상승에 의해 견인되고 있습니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 치료 기기 수탁제조 시장의 변수, 동향, 범위
시장 계통 전망
시장 역학
시장 성장 촉진요인 분석
시장 성장 억제요인 분석
기술의 진보
임상시험 건수 분석(2024년)
치료 기기 수탁제조 시장의 분석 툴
업계 분석 - Porter's Five Forces 분석
PESTEL 분석
제4장 치료 기기 수탁제조 시장 : 제품별 추정 및 동향 분석
치료 기기 수탁제조 시장 : 제품별 부문 대시보드
치료 기기 수탁제조 시장 : 제품별 변동 분석
제품별, 2021-2033년
클래스 I
클래스 II
클래스 III
제5장 치료 기기 수탁제조 시장 : 서비스별 추정 및 동향 분석
치료 기기 수탁제조 시장 : 서비스별 부문 대시보드
치료 기기 수탁제조 시장 : 서비스별 변동 분석
서비스별, 2021-2033년
액세서리 제조
조립 제조
부품 제조
기기 제조
포장 및 라벨
기타
제6장 치료 기기 수탁제조 시장 : 치료 영역별 추정 및 동향 분석
치료 기기 수탁제조 시장 : 치료 영역별 부문 대시보드
치료 기기 수탁제조 시장 : 치료 영역별 변동 분석
치료 영역별, 2021-2033년
심장혈관 기기
정형외과용 기기
안과용 기기
호흡기용 기기
수술기구
치과
기타
제7장 치료 기기 수탁제조 시장 : 최종 용도별 추정 및 동향 분석
치료 기기 수탁제조 시장 : 최종 용도별 부문 대시보드
치료 기기 수탁제조 시장 : 최종 용도별 변동 분석
최종 용도별, 2021-2033년
OEM
제약 및 바이오 의약품 기업
제약 및 바이오 의약품 기업 시장, 2021-2033년
기타
제8장 치료 기기 수탁제조 시장 : 지역별 추정 및 동향 분석
지역별 시장 점유율 분석(2024년 및 2033년)
지역별 시장 대시보드
세계의 지역별 시장 현황
북미
유럽
영국
독일
프랑스
이탈리아
스페인
덴마크
스웨덴
노르웨이
아시아태평양
라틴아메리카
중동 및 아프리카
남아프리카
사우디아라비아
아랍에미리트(UAE)
쿠웨이트
오만
카타르
제9장 경쟁 구도
시장 진출기업의 분류
기업의 시장 점유율 분석, 2024년
기업 프로파일
Thermo Fisher Scientific Inc.
Integer Holdings Corporation
FLEX LTD.
Celestica Inc.
Phillips-Medisize
Plexus Corp
Nipro Corporation
Viant Technology LLC
West Pharmaceutical Services, Inc.
Synecco Ltd
제10장 주요 권장사항
JHS
영문 목차
Therapeutic Device Contract Manufacturing Market Summary
The global therapeutic device contract manufacturing market size was valued at USD 53.66 billion in 2024 and is projected to reach USD 159.76 billion by 2033, growing at a CAGR of 13.15% from 2025 to 2033. The market is driven by the increasing demand for advanced therapeutic devices, the rising trend of manufacturing outsourcing by medical device companies to reduce costs and accelerate time-to-market, and the growing prevalence of chronic diseases requiring innovative treatment solutions.
Global Therapeutic Device Contract Manufacturing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global therapeutic device contract manufacturing market report based on product, services, therapeutic area, end-use, and region.
Product Outlook (Revenue, USD Million, 2021 - 2033)
Class I
Class II
Class III
Services Outlook (Revenue, USD Million, 2021 - 2033)
Accessories Manufacturing
Assembly Manufacturing
Component Manufacturing
Device Manufacturing
Packaging and Labeling
Others
Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
Cardiovascular Devices
Orthopedic Devices
Ophthalmic Devices
Respiratory Devices
Surgical Instruments
Dental
Others
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Original Equipment Manufacturers (OEMs)
Pharmaceutical & Biopharmaceutical Companies
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Services
1.2.3. Therapeutic Area
1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR's Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Therapeutic Device Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technological Advancements
3.4. Clinical trials volume analysis (2024)
3.5. Therapeutic Device Contract Manufacturing Market Analysis Tools
3.5.1. Industry Analysis - Porter's Five Analysis
3.5.2. PESTEL Analysis
Chapter 4. Therapeutic Device Contract Manufacturing Market: Product Estimates & Trend Analysis
4.1. Therapeutic Device Contract Manufacturing Market, By Product: Segment Dashboard
4.2. Therapeutic Device Contract Manufacturing Market, By Product: Movement Analysis
4.3. Therapeutic Device Contract Manufacturing Market Estimates & Forecasts, By Product, 2021 - 2033
4.4. Class I
4.4.1. Class I Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Class II
4.5.1. Class II Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Class III
4.6.1. Class III Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Therapeutic Device Contract Manufacturing Market: Services Estimates & Trend Analysis
5.1. Therapeutic Device Contract Manufacturing Market, By Services: Segment Dashboard
5.2. Therapeutic Device Contract Manufacturing Market, By Services: Movement Analysis
5.3. Therapeutic Device Contract Manufacturing Market Estimates & Forecasts, By Services, 2021 - 2033
5.4. Accessories Manufacturing
5.4.1. Accessories Manufacturing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Assembly Manufacturing
5.5.1. Assembly Manufacturing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Component Manufacturing
5.6.1. Component Manufacturing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Device Manufacturing
5.7.1. Device Manufacturing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Packaging and Labeling
5.8.1. Packaging and Labeling Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Therapeutic Device Contract Manufacturing Market: Therapeutic Area Estimates & Trend Analysis
6.1. Therapeutic Device Contract Manufacturing Market, By Therapeutic Area: Segment Dashboard
6.2. Therapeutic Device Contract Manufacturing Market, By Therapeutic Area: Movement Analysis
6.3. Therapeutic Device Contract Manufacturing Market Estimates & Forecasts, By Synthesis, 2021 - 2033
6.4. Cardiovascular Devices
6.4.1. Cardiovascular Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Orthopedic Devices
6.5.1. Orthopedic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Ophthalmic Devices
6.6.1. Ophthalmic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Respiratory Devices
6.7.1. Respiratory Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Surgical Instruments
6.8.1. Surgical Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Dental
6.9.1. Dental Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Therapeutic Device Contract Manufacturing Market: End Use Estimates & Trend Analysis
7.1. Therapeutic Device Contract Manufacturing Market, By End Use: Segment Dashboard
7.2. Therapeutic Device Contract Manufacturing Market, By End Use: Movement Analysis
7.3. Therapeutic Device Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033
7.4. Original Equipment Manufacturers (OEMs)
7.4.1. Original Equipment Manufacturers (OEMs) Market, 2021 to 2033, (USD Million)
7.5. Pharmaceutical & Biopharmaceutical Companies
7.5.1. Pharmaceutical & Biopharmaceutical Companies Market, 2021 to 2033, (USD Million)
7.6. Others
7.6.1. Others Market, 2021 to 2033, (USD Million)
Chapter 8. Therapeutic Device Contract Manufacturing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.2. U.S
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Europe
8.5.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Competitive Scenario
8.5.9.3. Regulatory Framework
8.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.5. Thailand
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.7. Australia
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Latin America
8.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. MEA
8.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competitive Scenario
8.8.5.3. Regulatory Framework
8.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.6. Oman
8.8.6.1. Key Country Dynamics
8.8.6.2. Competitive Scenario
8.8.6.3. Regulatory Framework
8.8.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.7. Qatar
8.8.7.1. Key Country Dynamics
8.8.7.2. Competitive Scenario
8.8.7.3. Regulatory Framework
8.8.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Share Analysis, 2024
9.3. Company Profiles
9.3.1. Thermo Fisher Scientific Inc.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Integer Holdings Corporation
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. FLEX LTD.
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Celestica Inc.
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Phillips-Medisize
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Plexus Corp
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Nipro Corporation
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Viant Technology LLC
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. West Pharmaceutical Services, Inc.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Synecco Ltd
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
Chapter 10. Key Recommendations
관련자료
